Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer (NCT04905069)

🧪 Interventions in This Study

• SpaceOAR Vue System (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (30 Sites)

Showing the first 25 of 30 sites.

• GenesisCare USA — Fort Myers, Florida
• Florida Urology Partners, LLC — Tampa, Florida
• Kansas University Medical Center — Kansas City, Kansas
• GenesisCare USA — Troy, Michigan
• New Jersey Urology, a Summit Health Company — Bloomfield, New Jersey
• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
• Dr. John Sylvester — Myrtle Beach, South Carolina
• Calvary Mater Newcastle — Waratah, New South Wales
• Princess Alexandra Hospital - ROPAIR — Woolloongabba, Queensland
• Sir Charles Gairdner Hospital — Nedlands, Western Australia
• Institut Gustave Roussy — Villejuif, Cedex
• Institut de Radiothérapie & Radiochirurgie HARTMANN — Levallois-Perret,
• MEDICLIN Robert Janker Klinik — Bonn,
• Klinikum Nurnberg Nord — Nuremberg,
• Bon Secours Radiotherapy Cork — Cork,
• Azienda Ospedaliero Universitaria di Parma — Parma,
• Policlinico Universitario Agostino Gemelli — Rome,
• IRCCS Ospedale Sacro Cuore Don Calabria — Verona,
• Hospital Universitario Cruces — Barakaldo,
• GenesisCare, Hospital San Francisco de Asis — Madrid,
• Hospital Universitario Ramón y Cajal — Madrid,
• University Hospital Basel — Basel,
• Inselspital - University Hospital Bern — Bern,
• Royal Surrey County Hospital NHS Foundation Trust — Guildford, Surrey
• Velindre Cancer Centre — Cardiff, Wales

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Prostate Cancer

• A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC — Homewood, Alabama
• A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described — Homewood, Alabama
• Stereotactic Ablative Radiation Therapy for Prostate Cancer — Charleston, South Carolina
• A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer — Basking Ridge, New Jersey
• A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer — Phoenix, Arizona
• Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer — Baltimore, Maryland

Explore by condition: All Prostate Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.